Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-β1

S MoriguchiY MaeharaD KorenagaK SugimachiY NoseRisk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurg Oncol1341346199210.1016/0960-7404(92)90034-I1341269

U Ribeiro JrJJ Gama-RodriguesAV Safatle-RibeiroPrognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancerJ Gastrointest Surg2244249199810.1016/S1091-255X(98)80019-X9841981

E BandoY YonemuraY TakeshitaIntraoperative lavage for cytological examination in 1,297 patients with gastric carcinomaAm J Surg178256262199910.1016/S0002-9610(99)00162-210527450

CH YooSH NohDW ShinSH ChoiJS MinRecurrence following curative resection for gastric carcinomaBr J Surg87236242200010.1046/j.1365-2168.2000.01360.x10671934

K MaruyamaZ SelmaniH IshiiK YamaguchiInnate immunity and cancer therapyInt Immunopharmacol11350357201110.1016/j.intimp.2010.09.012

SJ OosterlingGJ van der BijM BogelsJR van der SijpRH BeelenS MeijerM van EgmondInsufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual diseaseCancer Immunol Immunother5510431051200610.1007/s00262-005-0101-y

A MantovaniS SozzaniM LocatiP AllavenaA SicaMacrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytesTrends Immunol23549555200210.1016/S1471-4906(02)02302-512401408

A MantovaniA SicaS SozzaniP AllavenaA VecchiM LocatiThe chemokine system in diverse forms of macrophage activation and polarizationTrends Immunol25677686200410.1016/j.it.2004.09.01515530839

A MantovaniA SicaMacrophages, innate immunity and cancer: balance, tolerance, and diversityCurr Opin Immunol22231237201010.1016/j.coi.2010.01.00920144856

SS QianJ GaoJX WangY LiuHY DongEstablishment of a mouse forestomach carcinoma cell line with spontaneous hematogenous metastasis and preliminary study of its biological characteristicsZhonghua Zhong Liu Za Zhi926126419873678016

DM MosserJP EdwardsExploring the full spectrum of macrophage activationNat Rev Immunol8958969200810.1038/nri244819029990

S GoerdtCE OrfanosOther functions, other genes: alternative activation of antigen-presenting cellsImmunity10137142199910.1016/S1074-7613(00)80014-X10072066

SA BensonJD ErnstTLR2-dependent inhibition of macrophage responses to IFN-γ is mediated by distinct, gene-specific mechanismsPLoS One4e63292009

A WuJ WeiLY KongGlioma cancer stem cells induce immunosuppressive macrophages/microgliaNeuro Oncol1211131125201010.1093/neuonc/noq08220667896

J O'BrienP SchedinMacrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer?J Mammary Gland Biol Neoplasia14145157200910.1007/s10911-009-9118-819350209

YW LiSJ QiuJ FanTumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resectionJ Cancer Res Clin Oncol135439449200910.1007/s00432-008-0469-018781326

GC BlobeWP SchiemannHF LodishRole of transforming growth factor β in human diseaseN Engl J Med342135013582000

GJ InmanSwitching TGFβ from a tumor suppressor to a tumor promoterCurr Opin Genet Dev2193992011

Y LinS KikuchiY ObataK YagyuSerum levels of transforming growth factor β1 are significantly correlated with venous invasion in patients with gastric cancerJ Gastroenterol Hepatol214324372006

O ShintoM YashiroH KawajiriK ShimizuT ShimizuA MiwaK HirakawaInhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cellsBr J Cancer1028448512010